Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1085

1.

The Isometric Quadriceps Contraction Method for Intra-Articular Knee Injection.

Wada M, Fujii T, Inagaki Y, Nagano T, Tanaka Y.

JBJS Essent Surg Tech. 2019 May 8;9(2):e16. doi: 10.2106/JBJS.ST.18.00056. eCollection 2019 Jun 26.

2.

Left Ventricular Diastolic Function During the Normal Peripartum Period.

Kimura Y, Kato T, Miyata H, Sasaki I, Minamino-Muta E, Nagasawa Y, Numao S, Nagano T, Higuchi T, Inoko M.

Circ J. 2019 Sep 22. doi: 10.1253/circj.CJ-19-0501. [Epub ahead of print]

3.

Organic resolution function and effects of platinum nanoparticles on bacteria and organic matter.

Itohiya H, Matsushima Y, Shirakawa S, Kajiyama S, Yashima A, Nagano T, Gomi K.

PLoS One. 2019 Sep 19;14(9):e0222634. doi: 10.1371/journal.pone.0222634. eCollection 2019.

4.

A multi-center, Phase II trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

Tachihara M, Kiriu T, Hata A, Hatakeyama Y, Nakata K, Nagano T, Yamamoto M, Kobayashi K, Ohnishi H, Katakami N, Nishimura Y.

Cancer Manag Res. 2019 Jul 29;11:7135-7140. doi: 10.2147/CMAR.S208224. eCollection 2019.

5.

Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials.

Nagano T, Katsurada M, Yasuda Y, Kobayashi K, Nishimura Y.

Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619875925. doi: 10.1177/1753466619875925.

6.

Cerebral arterial air emboli after stent insertion in esophageal cancer complicated with esophago-left atrial fistula: An autopsy case and review of the literature.

Park JK, Goto T, Nagano T, Yoshimura M, Yutani C.

Pathol Int. 2019 Sep 11. doi: 10.1111/pin.12849. [Epub ahead of print]

PMID:
31508866
7.

Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y, Michitaka K; On behalf of the Real-Life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Oncology. 2019 Aug 29:1-7. doi: 10.1159/000502095. [Epub ahead of print]

PMID:
31466068
8.

Distinct Modified Nucleosides in tRNATrp from the Hyperthermophilic Archaeon Thermococcus kodakarensis and Requirement of tRNA m2G10/m2 2G10 Methyltransferase (Archaeal Trm11) for Survival at High Temperatures.

Hirata A, Suzuki T, Nagano T, Fujii D, Okamoto M, Sora M, Lowe TM, Kanai T, Atomi H, Suzuki T, Hori H.

J Bacteriol. 2019 Oct 4;201(21). pii: e00448-19. doi: 10.1128/JB.00448-19. Print 2019 Nov 1.

PMID:
31405913
9.

Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Tanaka H, Tamai T, Koizumi Y, Hiasa Y, Michitaka K, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group; HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Oncology. 2019 Jul 15:1-9. doi: 10.1159/000501281. [Epub ahead of print]

PMID:
31307035
10.

Possible Biomarkers for Cancer Immunotherapy.

Otoshi T, Nagano T, Tachihara M, Nishimura Y.

Cancers (Basel). 2019 Jul 3;11(7). pii: E935. doi: 10.3390/cancers11070935. Review.

11.

Design and Synthesis of an Activatable Photoacoustic Probe for Hypochlorous Acid.

Ikeno T, Hanaoka K, Iwaki S, Myochin T, Murayama Y, Ohde H, Komatsu T, Ueno T, Nagano T, Urano Y.

Anal Chem. 2019 Jul 16;91(14):9086-9092. doi: 10.1021/acs.analchem.9b01529. Epub 2019 Jul 2.

PMID:
31265237
12.

Influence of the aldehyde dehydrogenase 2 polymorphism on the vasodilatory effect of nitroglycerin in infants with congenital heart disease and pulmonary arterial hypertension.

Nagano T, Ushijima K, Taga N, Takeuchi M, Kawada MA, Aizawa K, Imai Y, Fujimura A.

Eur J Clin Pharmacol. 2019 Oct;75(10):1361-1367. doi: 10.1007/s00228-019-02709-x. Epub 2019 Jun 27.

PMID:
31250045
13.

Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review.

Murakami S, Nagano T, Nakata K, Onishi A, Umezawa K, Katsurada N, Yamamoto M, Tachihara M, Kobayashi K, Nishimura Y.

Intern Med. 2019 Oct 1;58(19):2839-2843. doi: 10.2169/internalmedicine.2556-19. Epub 2019 Jun 27.

14.

Methylene chain ruler for evaluating the regioselectivity of a substrate-recognising oxidation catalyst.

Teramae S, Kito A, Shingaki T, Hamaguchi Y, Yano Y, Nakayama T, Kobayashi Y, Kato N, Umezawa N, Hisamatsu Y, Nagano T, Higuchi T.

Chem Commun (Camb). 2019 Jul 25;55(58):8378-8381. doi: 10.1039/c9cc03041g. Epub 2019 Jun 24.

PMID:
31233056
15.

Abnormal menstruation after radical trachelectomy and its effects on fertility.

Matsuoka M, Taga A, Hata S, Yamamoto R, Ando Y, Kozono Y, Tsuji N, Sekiyama K, Higuchi T, Nagano T.

J Obstet Gynaecol Res. 2019 Sep;45(9):1906-1912. doi: 10.1111/jog.14032. Epub 2019 Jun 19.

PMID:
31215125
16.

Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years.

Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura M, Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MM, Ueland FR, Kelley JL, Roman LD.

Surg Oncol. 2019 Jun;29:25-32. doi: 10.1016/j.suronc.2019.02.002. Epub 2019 Feb 7.

PMID:
31196490
17.

Novel cancer therapy targeting microbiome.

Nagano T, Otoshi T, Hazama D, Kiriu T, Umezawa K, Katsurada N, Nishimura Y.

Onco Targets Ther. 2019 May 13;12:3619-3624. doi: 10.2147/OTT.S207546. eCollection 2019. Review.

18.

Crucial Role of Extracellular Vesicles in Bronchial Asthma.

Nagano T, Katsurada M, Dokuni R, Hazama D, Kiriu T, Umezawa K, Kobayashi K, Nishimura Y.

Int J Mol Sci. 2019 May 27;20(10). pii: E2589. doi: 10.3390/ijms20102589. Review.

19.

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y, Michitaka K, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group, HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Cancer Med. 2019 Jul;8(8):3719-3728. doi: 10.1002/cam4.2241. Epub 2019 May 24.

20.

Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines.

Effendi WI, Nagano T, Tachihara M, Umezawa K, Kiriu T, Dokuni R, Katsurada M, Yamamoto M, Kobayashi K, Nishimura Y.

Cancer Manag Res. 2019 Apr 29;11:3669-3679. doi: 10.2147/CMAR.S193789. eCollection 2019.

21.

Outcomes of radiotherapy in advanced external auditory canal cancer.

Nagano T, Yoshimura RI, Kojima M, Nakagawa K, Toda K.

J Radiat Res. 2019 May 1;60(3):380-386. doi: 10.1093/jrr/rrz010.

22.

Dacomitinib, a second-generation irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) to treat non-small cell lung cancer.

Nagano T, Tachihara M, Nishimura Y.

Drugs Today (Barc). 2019 Apr;55(4):231-236. doi: 10.1358/dot.2019.55.4.2965337. Review.

PMID:
31050691
23.

EFFECTS OF INTRAPERITONEAL GLUTAMINE IN THE TREATMENT OF EXPERIMENTAL SEPSIS.

Stonoga ETS, Bueno RZ, Nagano TA, Martins V, Rocha SL.

Arq Bras Cir Dig. 2019;32(2):e1431. doi: 10.1590/0102-672020190001e1431. Epub 2019 Apr 29. English, Portuguese.

24.

Questionnaire Survey for Bronchial Asthma in Elderly Care Facilities.

Shinke H, Kamiryo H, Umezawa K, Hori S, Nakata K, Nagano T, Hazeki N, Kobayashi K, Fukabori T, Nishimura Y.

Kobe J Med Sci. 2019 Feb 13;64(5):E174-E179.

25.

Potential function of TGF-β isoforms in maturation-stage ameloblasts.

Okubo M, Chiba R, Karakida T, Yamazaki H, Yamamoto R, Kobayashi S, Niwa T, Margolis HC, Nagano T, Yamakoshi Y, Gomi K.

J Oral Biosci. 2019 Mar;61(1):43-54. doi: 10.1016/j.job.2018.12.002. Epub 2019 Jan 3.

PMID:
30929801
26.

Overexpression of CD 133 and BCL-2 in non-small cell lung cancer with neuroendocrine differentiation after transformation in ALK rearrangement-positive adenocarcinoma.

Koyama K, Katsurada N, Jimbo N, Tachihara M, Tamura D, Nakata K, Nagano T, Yamamoto M, Kamiryo H, Kobayashi K, Itoh T, Nishimura Y.

Pathol Int. 2019 May;69(5):294-299. doi: 10.1111/pin.12782. Epub 2019 Mar 22.

PMID:
30900377
27.

Effects of Anti-Glaucoma Prostaglandin Ophthalmic Solutions on Cultured Human Corneal Epithelial Cells.

Tong L, Matsuura E, Takahashi M, Nagano T, Kawazu K.

Curr Eye Res. 2019 Aug;44(8):856-862. doi: 10.1080/02713683.2019.1597127. Epub 2019 Apr 2.

PMID:
30884982
28.

Isometric Contraction of the Quadriceps Improves the Accuracy of Intra-Articular Injections into the Knee Joint via the Superolateral Approach.

Wada M, Fujii T, Inagaki Y, Nagano T, Tanaka Y.

JB JS Open Access. 2018 Oct 23;3(4):e0003. doi: 10.2106/JBJS.OA.18.00003. eCollection 2018 Dec 20.

29.

Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan.

Takaguchi K, Toyoda H, Tsutsui A, Suzuki Y, Nakamuta M, Imamura M, Senoh T, Nagano T, Tada T, Tachi Y, Hiraoka A, Michitaka K, Shibata H, Joko K, Okubo H, Tsuji K, Takaki S, Watanabe T, Ogawa C, Chayama K, Kumada T, Kudo M, Kumada H.

J Gastroenterol. 2019 Aug;54(8):742-751. doi: 10.1007/s00535-019-01568-8. Epub 2019 Mar 8.

PMID:
30848363
30.

A Cross-sectional Survey of the Clinical Manifestations and Underlying Illness of Cough.

Otoshi T, Nagano T, Funada Y, Takenaka K, Nakata H, Ohnishi H, Nishiuma T, Nakajima T, Kageshita T, Tsuchiya T, Yamamoto M, Kobayashi K, Nishimura Y.

In Vivo. 2019 Mar-Apr;33(2):543-549. doi: 10.21873/invivo.11508.

31.

Factors associated with increased levels of brain natriuretic peptide and cardiac troponin I during the peripartum period.

Kimura Y, Kato T, Miyata H, Sasaki I, Minamino-Muta E, Nagasawa Y, Numao S, Nagano T, Higuchi T, Inoko M.

PLoS One. 2019 Feb 7;14(2):e0211982. doi: 10.1371/journal.pone.0211982. eCollection 2019.

32.

An Open-Label, Multi-Institutional, Randomized Study to Evaluate the Additive Effect of a Leukotriene Receptor Antagonist on Cough Score in Patients with Cough-Variant Asthma Being Treated with Inhaled Corticosteroids.

Miwa N, Nagano T, Ohnishi H, Nishiuma T, Takenaka K, Shirotani T, Nakajima T, Dokuni R, Kawa Y, Kobayashi K, Funada Y, Kotani Y, Nishimura Y.

Kobe J Med Sci. 2018 Dec 4;64(4):E134-E139.

33.

Effects of Microbial Metabolites of (-)-Epigallocatechin Gallate on Glucose Uptake in L6 Skeletal Muscle Cell and Glucose Tolerance in ICR Mice.

Takagaki A, Yoshioka Y, Yamashita Y, Nagano T, Ikeda M, Hara-Terawaki A, Seto R, Ashida H.

Biol Pharm Bull. 2019;42(2):212-221. doi: 10.1248/bpb.b18-00612.

34.

Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer.

Katsurada M, Nagano T, Tachihara M, Kiriu T, Furukawa K, Koyama K, Otoshi T, Sekiya R, Hazama D, Tamura D, Nakata K, Katsurada N, Yamamoto M, Kobayashi K, Nishimura Y.

Anticancer Res. 2019 Feb;39(2):815-825. doi: 10.21873/anticanres.13180.

PMID:
30711962
35.

Case Report: Acute Generalized Exanthematous Pustulosis Caused by Praziquantel.

Shindo T, Masuda Y, Imai Y, Nagano T, Nishioka H.

Am J Trop Med Hyg. 2019 Mar;100(3):700-702. doi: 10.4269/ajtmh.18-0832.

PMID:
30675838
36.

d-amino acid oxidase promotes cellular senescence via the production of reactive oxygen species.

Nagano T, Yamao S, Terachi A, Yarimizu H, Itoh H, Katasho R, Kawai K, Nakashima A, Iwasaki T, Kikkawa U, Kamada S.

Life Sci Alliance. 2019 Jan 18;2(1). pii: e201800045. doi: 10.26508/lsa.201800045. Print 2019 Feb.

37.

Phospholipase Cε plays a crucial role in neutrophilic inflammation accompanying acute lung injury through augmentation of CXC chemokine production from alveolar epithelial cells.

Umezawa K, Nagano T, Kobayashi K, Dokuni R, Katsurada M, Yamamoto M, Yoshikawa Y, Kataoka T, Nishimura Y.

Respir Res. 2019 Jan 11;20(1):9. doi: 10.1186/s12931-019-0975-4.

38.

Graft-versus-host disease-Induced esophageal web.

Watari T, Nagano T, Takinami Y.

J Gen Fam Med. 2018 Oct 11;20(1):33-34. doi: 10.1002/jgf2.215. eCollection 2019 Jan.

39.

Successful Treatment of ROS1-rearranged Lung Cancer Complicated by Hypertrophic Pulmonary Osteoarthropathy with Crizotinib Therapy.

Katsurada N, Tachihara M, Jimbo N, Koyama K, Nakata K, Nagano T, Yamamoto M, Kamiryo H, Kobayashi K, Nishimura Y.

Intern Med. 2019 May 15;58(10):1467-1471. doi: 10.2169/internalmedicine.1982-18. Epub 2019 Jan 10.

40.

Size Distribution of Droplets in a Two Liquid-phase Mixture Compared between Liquid Spraying and Mechanical Stirring.

Shimogouchi T, Naganawa H, Nagano T, Grambow B, Nagame Y.

Anal Sci. 2019 Sep 10;35(9):955-960. doi: 10.2116/analsci.18P508. Epub 2019 Jan 4.

41.

[Measures taken by public health centers in Kumamoto, Japan, during the hyperacute phase to subacute phase of the Kumamoto earthquake].

Tsurugi Y, Ikeda Y, Inada T, Ogata K, Kiwaki K, Komiya S, Nagano T, Hattori K, Hayashida Y, Fuchigami A.

Nihon Koshu Eisei Zasshi. 2018;65(12):755-768. doi: 10.11236/jph.65.12_755. Japanese. No abstract available.

42.

Prognostic Value of Red Blood Cell Distribution Width in Non-small Cell Lung Cancer Treated With Anti-programmed Cell Death-1 Antibody.

Kiriu T, Yamamoto M, Nagano T, Koyama K, Katsurada M, Tamura D, Nakata K, Tachihara M, Kobayashi K, Nishimura Y.

In Vivo. 2019 Jan-Feb;33(1):213-220. doi: 10.21873/invivo.11462.

43.

Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer.

Nagano T, Tachihara M, Nishimura Y.

Curr Cancer Drug Targets. 2018 Dec 9. doi: 10.2174/1568009619666181210114559. [Epub ahead of print]

PMID:
30526458
44.

Impact of soymilk consumption on 2,4-dinitrofluorobenzene-induced contact hypersensitivity and gut microbiota in mice.

Nagano T, Katase M, Tsumura K.

Int J Food Sci Nutr. 2019 Aug;70(5):579-584. doi: 10.1080/09637486.2018.1547689. Epub 2018 Dec 2.

PMID:
30501551
45.

Performance of a flat-field grating spectrometer for tender x-ray emission spectroscopy.

Imazono T, Ukita R, Nishihara H, Sasai H, Nagano T.

Appl Opt. 2018 Sep 20;57(27):7770-7777. doi: 10.1364/AO.57.007770.

PMID:
30462040
46.

Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy.

Nagano T, Tachihara M, Nishimura Y.

Cells. 2018 Nov 15;7(11). pii: E212. doi: 10.3390/cells7110212. Review.

47.

Serum selenoprotein P, but not selenium, predicts future hyperglycemia in a general Japanese population.

Oo SM, Misu H, Saito Y, Tanaka M, Kato S, Kita Y, Takayama H, Takeshita Y, Kanamori T, Nagano T, Nakagen M, Urabe T, Matsuyama N, Kaneko S, Takamura T.

Sci Rep. 2018 Nov 13;8(1):16727. doi: 10.1038/s41598-018-35067-2.

48.

Inexpensive High-Throughput Screening of Kinase Inhibitors Using One-Step Enzyme-Coupled Fluorescence Assay for ADP Detection.

Imamura RM, Kumagai K, Nakano H, Okabe T, Nagano T, Kojima H.

SLAS Discov. 2019 Mar;24(3):284-294. doi: 10.1177/2472555218810139. Epub 2018 Nov 12.

PMID:
30418800
49.

Diets containing pomegranate polyphenol and soy isoflavone attenuate contact hypersensitivity in mice.

Nagano T, Ito H.

Biosci Biotechnol Biochem. 2019 Mar;83(3):525-530. doi: 10.1080/09168451.2018.1543013. Epub 2018 Nov 10.

PMID:
30417760
50.

Post-irrigation degradation of land and environmental resources in the Harran plain, southeastern Turkey.

Bilgili AV, Yeşilnacar İ, Akihiko K, Nagano T, Aydemir A, Hızlı HS, Bilgili A.

Environ Monit Assess. 2018 Oct 22;190(11):660. doi: 10.1007/s10661-018-7019-2.

PMID:
30345489

Supplemental Content

Loading ...
Support Center